KR950700412A - Protein components that inhibit tumor growth (PROTEIN COMPOUND CAPABLE OF INHIBITING TUMORAL GROWTH) - Google Patents

Protein components that inhibit tumor growth (PROTEIN COMPOUND CAPABLE OF INHIBITING TUMORAL GROWTH)

Info

Publication number
KR950700412A
KR950700412A KR1019940703052A KR19940703052A KR950700412A KR 950700412 A KR950700412 A KR 950700412A KR 1019940703052 A KR1019940703052 A KR 1019940703052A KR 19940703052 A KR19940703052 A KR 19940703052A KR 950700412 A KR950700412 A KR 950700412A
Authority
KR
South Korea
Prior art keywords
protein
growth
compound capable
inhibit tumor
tumor growth
Prior art date
Application number
KR1019940703052A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITRM920161A external-priority patent/IT1255038B/en
Priority claimed from IT92RM716 external-priority patent/IT1262997B/en
Application filed filed Critical
Publication of KR950700412A publication Critical patent/KR950700412A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1019940703052A 1992-03-09 1994-09-01 Protein components that inhibit tumor growth (PROTEIN COMPOUND CAPABLE OF INHIBITING TUMORAL GROWTH) KR950700412A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM920161A IT1255038B (en) 1992-03-09 1992-03-09 Mammal cell line and conditioned culture medium
IT92RM716 IT1262997B (en) 1992-09-30 1992-09-30 New protein homologous to human heat shock P27 protein - is obtd. from liposarcoma cells, used for treating oestrogen-dependent epithelial tumours
PCT/IT1993/000020 WO1993018147A1 (en) 1992-03-09 1993-03-08 Protein compound capable of inhibiting tumoral growth

Publications (1)

Publication Number Publication Date
KR950700412A true KR950700412A (en) 1995-01-16

Family

ID=26332011

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703052A KR950700412A (en) 1992-03-09 1994-09-01 Protein components that inhibit tumor growth (PROTEIN COMPOUND CAPABLE OF INHIBITING TUMORAL GROWTH)

Country Status (7)

Country Link
EP (1) EP0630404A1 (en)
KR (1) KR950700412A (en)
CN (1) CN1078494A (en)
CA (1) CA2130089A1 (en)
FI (1) FI944102A (en)
HU (1) HUT70972A (en)
WO (1) WO1993018147A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US5948646A (en) * 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
EP1829551B1 (en) 1998-02-20 2010-09-29 University of Miami Modified heat shock protein-antigenic peptide complex
AU2001266694C1 (en) 2000-06-02 2005-09-01 University Of Connecticut Health Center Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
WO2003015712A2 (en) 2001-08-20 2003-02-27 University Of Connecticut Health Center Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
ITMI20020404A1 (en) * 2002-02-28 2003-08-28 Ist Naz Stud Cura Dei Tumori NEW MANGANESE SUPEROXIDE HUMAN DISMUTATION
CN102014937A (en) 2008-03-03 2011-04-13 迈阿密大学 Allogeneic cancer cell-based immunotherapy
JP2011515399A (en) 2008-03-20 2011-05-19 ユニバーシティー オブ マイアミ Heat shock protein GP96 vaccination and method using the same
WO2016127015A1 (en) 2015-02-06 2016-08-11 Heat Biologics, Inc. Vector co-expressing vaccine and costimulatory molecules
US11666649B2 (en) 2016-10-11 2023-06-06 University Of Miami Vectors and vaccine cells for immunity against Zika virus
US11548930B2 (en) 2017-04-04 2023-01-10 Heat Biologics, Inc. Intratumoral vaccination

Also Published As

Publication number Publication date
FI944102A0 (en) 1994-09-07
HU9402317D0 (en) 1994-10-28
CA2130089A1 (en) 1993-09-16
CN1078494A (en) 1993-11-17
WO1993018147A1 (en) 1993-09-16
EP0630404A1 (en) 1994-12-28
FI944102A (en) 1994-09-07
HUT70972A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
KR950700412A (en) Protein components that inhibit tumor growth (PROTEIN COMPOUND CAPABLE OF INHIBITING TUMORAL GROWTH)
DE69333179D1 (en) Stabilization of polybutylene terephthalate-polyester mixtures
DE69315842D1 (en) PEPTIDE COMPOUNDS
DE69413815D1 (en) Inhibition of hair growth
DE69427756D1 (en) INHIBITION OF HAIR GROWTH
KR950700875A (en) PREPARATION OF SUBSTITUTED GUANIDINES
DE69220382D1 (en) Use of peptide derivatives
NO932388L (en) Procedures for fracture-acid treatment of underwater formations
ITMI931306A1 (en) MICROBIAL PROCEDURE FOR THE PREPARATION OF MEVINOLINA
DK0407343T3 (en) Method of combating fish lice
ITMI912025A0 (en) PROCEDURE FOR THE PREPARATION OF DEMETHYLEPIPODOPHYLLOTOXIN-BETA-DGLUCOSIDES
AU1783092A (en) Inhibitors of protein kinase c function
NO924815D0 (en) PROCEDURE FOR SURFACE TREATMENT OF AN OBJECTS
ITPD920013V0 (en) STRAP OF STRAP
KR950700011A (en) METHOD OF MANUFACTURING PRESERVED FOOD
DE69522888D1 (en) Epitaxial growth of semiconductor compounds
LV12073A (en) Saturation of diisopinocamphenylchlorborane
FI923360A (en) PROCEDURE FOR FRAMSTATION OF DIMETHYLACETOACETAMIDE
ITMI922181A0 (en) PROCEDURE FOR THE PREPARATION OF PERFLUORINE-2-METHYL-4-METHOXYPENTANE
KR930022688U (en) Aquarium for ornamental fish
KR930022697U (en) Lighting equipment of fish tank
EP0562624A3 (en) Stabilization of functional proteins
ITMI921833A1 (en) METHOD OF PREPARATION OF NIMESULIDE INCLUSION COMPOUNDS WITH CYCLODESTRINE
LV10825A (en) Saturation of rye homozygous lines
ITMI921096A1 (en) DOSER-APPLICATOR OF FISHING LEADS

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid